Cancer
📧 Sign up to get email alerts when something new happens for Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-07-01Clinical Trial Update: DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study) [Phase 1]
A phase 1 imaging study by AstraZeneca and Royal Marsden Hospital evaluating dynamic contrast-enhanced CT/MRI in patients with solid tumours…
-
CLINICAL_TRIALS research · 2011-07-01Clinical Trial Update: The Development and Testing of an Electronic Tool to Measure Physical Activity in Domestic Settings
The document reports on the development and testing of an electronic tool to measure physical activity in home settings as part of a cancer-…
-
CLINICAL_TRIALS other · 2011-06-30Clinical Trial Update: Pilot Study of Biomarkers for Radiation Therapy
Pilot study investigating biomarkers for radiation therapy in cancer is currently suspended. The snippet provides limited details about the …
-
CLINICAL_TRIALS research · 2011-06-30Clinical Trial Update: Cancer Patients' Knowledge About Fatigue [NA]
A clinical trial update from Oslo University Hospital about cancer patients' knowledge and understanding of fatigue, with no trial results r…
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: A Study of Therapeutic Amplitude-modulated Electromagnetic Fields in Advanced Tumors [EARLY_Phase 1]
An early-phase (Phase 1) study of therapeutic amplitude-modulated electromagnetic fields in patients with advanced cancers, including brain …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors [Phase 1]
Phase 1 study in Japan evaluating PF-00299804 in patients with advanced malignant solid tumors has completed, focusing on safety and tolerab…
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. [Phase 2]
Phase 2 trial evaluating Sativex for pain relief in patients with advanced cancer has completed, and results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks [Phase 2]
This document reports the completion of a Phase 2 study evaluating the efficacy and safety of PROCRIT (epoetin alfa) in cancer patients rece…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four Weeks [Phase 2]
Phase 2 trial assessing the efficacy and safety of PROCRIT (epoetin alfa) in cancer patients receiving chemotherapy (weekly or every four we…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Gene Therapy in Treating Patients With Cancer [Phase 1]
A Phase 1 clinical trial update for a gene therapy tested in patients with cancer, which has completed.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy. [Phase 3]
Phase 3 clinical trial evaluating the hematologic response (hemoglobin increase) to PROCRIT (epoetin alfa) given at 80,000 units weekly in c…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Palliative Care Study in Patients With Advanced Cancer [Phase 2]
This update notes that a Phase 2 palliative-care study in patients with advanced cancer was terminated. No efficacy or safety results are pr…
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer [Phase 1]
Phase 1 study assessing liposome-encapsulated mitoxantrone (LEM) in patients with advanced cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2011-05-27Clinical Trial Update: Safety Study of FLP Injection to Treat Tumor Patients [Phase 1]
Phase 1 safety study evaluating FLP injection in patients with cancer.
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer [NA]
This document reports a terminated clinical trial evaluating epoetin alfa for chemotherapy-related anemia in cancer patients, with results p…
-
CLINICAL_TRIALS research · 2011-05-24Clinical Trial Update: Pro-self Pain Management in Norway [NA]
Clinical trial update for Pro-self Pain Management in Norway, sponsored by Oslo University Hospital. The trial addressing cancer-related pai…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced Anemia [Phase 2]
This Phase 2 clinical trial update assesses alternate dosing regimens of epoetin alfa (PROCRIT) in cancer patients with chemotherapy-induced…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer [Phase 3]
Phase 3 trial evaluating the efficacy of the Fentanyl Transdermal Therapeutic System for cancer-related pain management.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer [Phase 3]
A Phase 3 trial update on the safety and clinical use of the Fentanyl Transdermal System for cancer-related pain, with the study status mark…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy. [Phase 3]
A Phase 3 study evaluating weekly 40,000 units of epoetin alfa (PROCRIT) in cancer patients with anemia who are not receiving chemotherapy w…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy [Phase 2]
Phase 2 study evaluating the safety and effectiveness of epoetin alfa for treating anemia in patients with advanced cancer undergoing aggres…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy [Phase 2]
Phase 2 trial evaluating epoetin alfa (PROCRIT) 60,000 units given every two weeks in anemic cancer patients not receiving chemotherapy or r…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy [Phase 3]
Phase 3 trial evaluating epoetin alfa for anemia in cancer patients receiving non-platinum chemotherapy has completed. The study was sponsor…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy [Phase 2]
Phase 2 study comparing PROCRIT (epoetin alfa) 80,000 units every four weeks with 40,000 units every two weeks in cancer patients not receiv…
-
CLINICAL_TRIALS withdrawal · 2011-05-16Clinical Trial Update: Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours [Phase 1]
The phase 1 trial of an mTOR kinase inhibitor in advanced solid tumors and lymphomas was withdrawn; no further results are reported.